These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects]. Sugiyama Y Nihon Rinsho; 2002 Sep; 60 Suppl 9():416-21. PubMed ID: 12387027 [No Abstract] [Full Text] [Related]
6. New drug overview. Pioglitazone hydrochloride. Am J Health Syst Pharm; 2000 Jan; 57(2):124-5. PubMed ID: 10688239 [No Abstract] [Full Text] [Related]
7. [Troglitazone: its pharmacology and mechanism of action]. Horikoshi H; Fujiwara T Nihon Rinsho; 1997 Nov; 55 Suppl():125-30. PubMed ID: 9434455 [No Abstract] [Full Text] [Related]
8. [Thiazolidinediones in type 2 diabetes]. Baum U Med Monatsschr Pharm; 2000 Jul; 23(7):210-3. PubMed ID: 10941251 [No Abstract] [Full Text] [Related]
9. Pharmacologic management of diabetes mellitus. Mozersky RP J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of thiazolidinediones. Flemmer M; Scott J Curr Opin Investig Drugs; 2001 Nov; 2(11):1564-7. PubMed ID: 11763158 [TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus. Medication update. Slagle M South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245 [No Abstract] [Full Text] [Related]
12. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes. Teter ML Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019 [No Abstract] [Full Text] [Related]